Drug Pipeline

Fisetin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
5
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-20 NCT06431932
Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity		 date change Completion moved earlier: 2034-06-01 -> 2028-12-31
Active Studies by Phase
Phase 2
3
Phase 1/2
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06399809 Fisetin to Reduce Senescence and Mobility Impairment in PAD Peripheral Arterial Disease Recruiting
NCT05593588 Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency Common Variable Immunodeficiency Enrolling by Invitation
NCT04733534 An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult… Frailty Active, Not Recruiting
Phase 1/2
NCT06431932 Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity Multimorbidity Recruiting
Early Phase 1
NCT07025226 Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or… Glioma Recruiting
Sponsors Running Fisetin Trials
St. Jude Children's Research Hospital (1) Avni Joshi (1) Northwestern University (1) Ove Andersen (1) Mayo Clinic (1)
Disease Areas
Glioma (1)
Get alerts when Fisetin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free